Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Common Equity (2016 - 2025)

Amn Healthcare Services' Common Equity history spans 16 years, with the latest figure at $642.1 million for Q4 2025.

  • For Q4 2025, Common Equity fell 9.13% year-over-year to $642.1 million; the TTM value through Dec 2025 reached $642.1 million, down 9.13%, while the annual FY2025 figure was $642.1 million, 9.13% down from the prior year.
  • Common Equity reached $642.1 million in Q4 2025 per AMN's latest filing, roughly flat from $644.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.2 billion in Q4 2021 to a low of $607.6 million in Q2 2025.
  • Average Common Equity over 5 years is $883.5 million, with a median of $883.8 million recorded in 2024.
  • Peak YoY movement for Common Equity: skyrocketed 41.77% in 2021, then plummeted 30.71% in 2025.
  • A 5-year view of Common Equity shows it stood at $1.2 billion in 2021, then dropped by 10.19% to $1.0 billion in 2022, then dropped by 20.35% to $831.3 million in 2023, then dropped by 14.99% to $706.6 million in 2024, then fell by 9.13% to $642.1 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's Common Equity are $642.1 million (Q4 2025), $644.4 million (Q3 2025), and $607.6 million (Q2 2025).